We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Vircell S.L.

Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the dia... read more Featured Products: More products

Download Mobile App





Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB

By LabMedica International staff writers
Posted on 05 Feb 2020
Print article
Illustration
Illustration
Vircell (Granada, Spain) exhibited its new instruments, VirClia Lotus and qSPEED-OLIGO, at MEDLAB Middle East, an event for showcasing the latest technology and knowledge in the IVD and medical laboratory market that was held at the Dubai International Convention and Exhibition Centre from February 3-6, 2020.

Vircell is a microbial biotechnology company which develops, manufactures and markets ready-to-use kits for the diagnosis of esoteric infectious diseases. It is specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques – ranging from the traditional cell culture to the most innovating developments in the field of molecular biology.

At this year’s MEDLAB Middle East, Vircell exhibited VirClia Lotus, its new Chemiluminescence system (CLIA) designed to process diagnostic immunoassays VirClia Monotest. The VirClia Lotus CLIA system offers random access with continuous loading, STAT function to manage urgent samples, and positive identification of samples and strips through an internal scanner. It delivers the firsts results in one hour (new result every 30 seconds), 40 tests in one hour 25 minutes, and 80 tests in two hours 30 minutes with a capacity of 50 primary tubes and/or aliquots.

Vircell also presented its new approach on molecular biology, the qSPEED-OLIGO which is a unique molecular diagnostic tool for real-time PCR multiplex testing of infectious diseases and offers automated identification of positive samples. The qSPEED-OLIGO system includes a two-channel fluorescence thermocycler which allows for the screening of all pathogens (FAM) and for the internal control and sample validation (HEX). It helps rapidly discard negatives and focus only on identifying positive samples. The benchtop modular instrument increases laboratory throughput with automated screening of 48 samples in less than 90 minutes. It provides the advantage of minimum hands-on-time protocol by using pre-dispensed qPCR tubes and sealed cassettes to rule out contamination.

Related Links:
Vircell

Gold Supplier
PS/PT ELISA
QUANTA Lite PS/PT
New
Auto Molecular Diagnostic System
ELITe InGenius
New
Thrombosis Viscoelasic Analysis System
ImproClot
New
Automatic Blood Coagulation Analyzer
BCA-3000

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.